214 related articles for article (PubMed ID: 21464042)
1. Interaction between FGFR-2, STAT5, and progesterone receptors in breast cancer.
Cerliani JP; Guillardoy T; Giulianelli S; Vaque JP; Gutkind JS; Vanzulli SI; Martins R; Zeitlin E; Lamb CA; Lanari C
Cancer Res; 2011 May; 71(10):3720-31. PubMed ID: 21464042
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.
Giulianelli S; Cerliani JP; Lamb CA; Fabris VT; Bottino MC; Gorostiaga MA; Novaro V; Góngora A; Baldi A; Molinolo A; Lanari C
Int J Cancer; 2008 Dec; 123(11):2518-31. PubMed ID: 18767044
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
[TBL] [Abstract][Full Text] [Related]
4. [The role of estrogen receptor alpha in breast cancer cell proliferation mediated by progestins].
Giulianelli S; Vaqué JP; Wargon V; Soldati R; Vanzulli SI; Martins R; Zeitlin E; Helguero L; Lamb C; Molinolo AA; Gutkind JS; Lanari C
Medicina (B Aires); 2012; 72(4):315-20. PubMed ID: 22892083
[TBL] [Abstract][Full Text] [Related]
5. Medroxyprogesterone acetate induces cell proliferation through up-regulation of cyclin D1 expression via phosphatidylinositol 3-kinase/Akt/nuclear factor-kappaB cascade in human breast cancer cells.
Saitoh M; Ohmichi M; Takahashi K; Kawagoe J; Ohta T; Doshida M; Takahashi T; Igarashi H; Mori-Abe A; Du B; Tsutsumi S; Kurachi H
Endocrinology; 2005 Nov; 146(11):4917-25. PubMed ID: 16123159
[TBL] [Abstract][Full Text] [Related]
6. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
Wiebe JP; Zhang G; Welch I; Cadieux-Pitre HA
Breast Cancer Res; 2013 May; 15(3):R38. PubMed ID: 25927181
[TBL] [Abstract][Full Text] [Related]
7. Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer.
Cerliani JP; Vanzulli SI; Piñero CP; Bottino MC; Sahores A; Nuñez M; Varchetta R; Martins R; Zeitlin E; Hewitt SM; Molinolo AA; Lanari C; Lamb CA
Breast Cancer Res Treat; 2012 Jun; 133(3):997-1008. PubMed ID: 22124578
[TBL] [Abstract][Full Text] [Related]
8. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
[TBL] [Abstract][Full Text] [Related]
9. Ligand- and cell-specific effects of signal transduction pathway inhibitors on progestin-induced vascular endothelial growth factor levels in human breast cancer cells.
Wu J; Brandt S; Hyder SM
Mol Endocrinol; 2005 Feb; 19(2):312-26. PubMed ID: 15528272
[TBL] [Abstract][Full Text] [Related]
10. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
[TBL] [Abstract][Full Text] [Related]
11. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
[TBL] [Abstract][Full Text] [Related]
12. Estradiol and medroxyprogesterone acetate regulated genes in T47D breast cancer cells.
Mrusek S; Classen-Linke I; Vloet A; Beier HM; Krusche CA
Mol Cell Endocrinol; 2005 May; 235(1-2):39-50. PubMed ID: 15866426
[TBL] [Abstract][Full Text] [Related]
13. Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects.
Bottino MC; Cerliani JP; Rojas P; Giulianelli S; Soldati R; Mondillo C; Gorostiaga MA; Pignataro OP; Calvo JC; Gutkind JS; Panomwat Amornphimoltham ; Molinolo AA; Lüthy IA; Lanari C
Breast Cancer Res Treat; 2011 Apr; 126(3):621-36. PubMed ID: 20535544
[TBL] [Abstract][Full Text] [Related]
14. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
[TBL] [Abstract][Full Text] [Related]
15. The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells.
Ghatge RP; Jacobsen BM; Schittone SA; Horwitz KB
Breast Cancer Res; 2005; 7(6):R1036-50. PubMed ID: 16457685
[TBL] [Abstract][Full Text] [Related]
16. MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements.
Giulianelli S; Herschkowitz JI; Patel V; Lamb CA; Gutkind JS; Molinolo A; Perou CM; Lanari C
Breast Cancer Res Treat; 2011 Aug; 129(1):49-67. PubMed ID: 20890655
[TBL] [Abstract][Full Text] [Related]
17. Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells.
Sarvilinna N; Eronen H; Miettinen S; Vienonen A; Ylikomi T
Int J Cancer; 2006 Feb; 118(4):832-40. PubMed ID: 16152593
[TBL] [Abstract][Full Text] [Related]
18. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
[TBL] [Abstract][Full Text] [Related]
19. PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer.
Riggio M; Polo ML; Blaustein M; Colman-Lerner A; Lüthy I; Lanari C; Novaro V
Carcinogenesis; 2012 Mar; 33(3):509-18. PubMed ID: 22180571
[TBL] [Abstract][Full Text] [Related]
20. Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.
Salatino M; Beguelin W; Peters MG; Carnevale R; Proietti CJ; Galigniana MD; Vedoy CG; Schillaci R; Charreau EH; Sogayar MC; Elizalde PV
Oncogene; 2006 Dec; 25(59):7723-39. PubMed ID: 16799639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
